Pharmacokinetic and pharmacodynamic behaviour of antitubercular drugs encapsulated in alginate nanoparticles at two doses

International Journal of Antimicrobial Agents
Zahoor AhmadG K Khuller

Abstract

This study was designed to evaluate the pharmacokinetics and tissue distribution of free and alginate-encapsulated antitubercular drugs in mice at different doses. Alginate nanoparticles encapsulating isoniazid (INH), rifampicin (RIF), pyrazinamide (PZA) and ethambutol (EMB) were prepared by controlled cation-induced gelification of alginate. The formulation was orally administered to mice at two dose levels (D1 and D2). A comparison was made in mice receiving free drugs at equivalent doses. Drugs were analysed by high performance liquid chromatography (HPLC). The average size of alginate nanoparticles was found to be 235.5+/-0.0 nm with a polydispersity index of 0.44; drug encapsulation was 70-90% for INH and PZA, 80-90% for RIF and 88-95% for EMB. In the free drug groups, plasma levels of RIF and INH were higher and PZA and EMB levels were lower in the D1 group (per body surface area of mice) compared with the D2 group (recommended human dose). The plasma drug levels of all drugs were higher in the D1 encapsulated group compared with D2, resulting in higher values of area under the plasma drug concentration-time curve (AUC(0-infinity)). The relative bioavailabilities of all drugs encapsulated in alginate nanoparticles were si...Continue Reading

Citations

Jun 20, 2007·Pharmaceutical Research·B SarmentoD Ferreira
Sep 21, 2006·Respiratory Research·Lisa Claire du ToitMichael Paul Danckwerts
Aug 7, 2013·Pulmonary Pharmacology & Therapeutics·Arpana Patil-Gadhe, Varsha Pokharkar
Apr 16, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Indu Pal Kaur, Harinder Singh
Sep 21, 2012·Journal of Microencapsulation·Hugo Costa, Ana Grenha
Dec 2, 2008·Expert Opinion on Drug Delivery·Zahoor Ahmad, G K Khuller
Oct 10, 2013·Expert Opinion on Drug Delivery·Admire DubeLonji Kalombo
Aug 28, 2012·Advanced Drug Delivery Reviews·Sotirios Koutsopoulos
Mar 30, 2010·The Journal of Infection·Anshika SharmaSadhna Sharma
Oct 9, 2008·Advanced Drug Delivery Reviews·Mehrdad HamidiPedram Rafiei
Dec 25, 2007·International Journal of Antimicrobial Agents·Zahoor AhmadG K Khuller
Jan 24, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jingxia GuLei Jiang
Jul 27, 2007·Nanomedicine : Nanotechnology, Biology, and Medicine·Zahoor AhmadGopal K Khuller
Aug 12, 2015·Chemical Reviews·Yulin LiHelena Tomás
Aug 26, 2014·Journal of Pharmaceutical and Biomedical Analysis·Subashini RajaramRajendran Natham
Apr 21, 2011·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Kyrre E EmblemA Gregory Sorensen
Aug 30, 2019·Current Pharmaceutical Design·Patricia SeverinoEliana B Souto
May 28, 2015·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Yuan ZhanPeixin He
Apr 1, 2020·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Dong ZhouYulin Li
Dec 29, 2020·Journal of Microbiological Methods·Madushani H Dahanayake, Anil C A Jayasundera
May 16, 2020·Materials Science & Engineering. C, Materials for Biological Applications·Alessandro L UrzedoAmedea B Seabra
Apr 3, 2020·Journal of Pharmaceutical Sciences·Priyanka S JahagirdarPadma V Devarajan
May 19, 2018·Drug Discovery Today·Arti VashistMadhavan Nair
Apr 10, 2021·International Journal of Biological Macromolecules·Jixian ZhangHonglei Tian
Jul 28, 2021·ACS Applied Materials & Interfaces·Moon Il KimTae Jung Park
Oct 27, 2017·ACS Applied Materials & Interfaces·Ping JiPeixin He
Apr 7, 2012·Drug Discovery Today·Devyani DubeSuresh P Vyas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.